drugset / Trial / NCT00238667
To Determine the Feasibility of a Clinical Trial Comparing Anticoagulants Versus Antiplatelets in the Acute Treatment of Patients With Cervical Artery Dissection
Phase 3
Completed
250 enrolled
St George's, University of London
The Stroke Association, United Kingdom · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a feasibility study to determine if a sufficient number of patients can be recruited throughout the United Kingdom and whether sufficient endpoints can be generated for a full scale therapeutic trial of anticoagulants versus antiplatelets in acute cervical artery dissection treatment.
Timeline
- Start
- 2005-11
- Primary completion
- —
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aspirin | Small molecule | 75 mg | — |
| Comparator | Aspirin | Small molecule | 300 mg | — |
| Comparator | Clopidogrel | Small molecule | — | — |
| Comparator | Dalteparin sodium | Other / unclassified | — | — |
| Comparator | Dipyridamole | Other / unclassified | — | — |
| Comparator | Enoxaparin sodium | Other / unclassified | — | — |
| Comparator | HEPARIN CALCIUM | Other / unclassified | — | — |
| Comparator | Tinzaparin | Other / unclassified | — | — |
| Comparator | Warfarin | Small molecule | — | — |